.png){kind=logo}
Apsis Aerocom IPO saw strong market demand with GMP (grey market premium) rising to Rs. 26, indicating a potential 23% listing gain and steady investor interest in niche SME manufacturing businesses.
Bluegod Entertainment raised Rs. 31.63 crore through a rights issue at Rs. 3 per share, offering existing shareholders a chance to increase holdings.
Global IPOs like PayPay and MiniMed raised $879 million and $560 million respectively, showing strong institutional demand for fintech and healthcare despite market volatility.
Markets are on edge as the US-Iran war escalates and surging oil prices continue to shake investor confidence. Equities have turned volatile, risk appetite has weakened, and traders are becoming more selective with fresh bets. While secondary markets struggle, IPO activity continues with strong participation in SME listings, large overseas offerings, and more. Grey market trends, subscription demand, and global listings are now key signals guiding investor interest.
Against this backdrop, these are the IPOs currently grabbing attention and driving the next wave of market opportunities.
Apsis Aerocom is a specialist in precision engineering, making parts for the aerospace, defense, and healthcare sectors. Their manufacturing hub in Bangalore uses advanced technology to create high-quality components for both Indian and international clients. This SME IPO opened on March 11 and closed on March 13, 2026. The company set its price band between Rs. 104 and Rs. 110 per share, aiming to raise about Rs. 35.77 crores through a fresh issue of shares. Each market lot consists of 2,400 shares, requiring a minimum investment of Rs. 2,64,000 at the top of the band.
For traders, the most exciting part is the Grey Market Premium (GMP). As of March 18, the Apsis Aerocom IPO GMP reached Rs. 26. This shows an expected return of roughly 23.64% over the issue price. While the GMP started at a low of Rs. 9 earlier in the month, it climbed steadily to a high of Rs. 26. The stock officially listed on the NSE SME platform on March 18, 2026, following an allotment process that finished on March 16.
Bluegod Entertainment, a company that has been around since 1984, is currently expanding its footprint in the media and digital content space. To fund this growth and new partnerships, the company launched a Rights Issue worth approximately Rs. 31.63 crores. This offer allowed existing shareholders to buy more shares at a fixed price of just Rs. 3 per share, which is quite low compared to the Rs. 1 face value. The window for this offer opened on March 12 and closed on March 19, 2026.
The company set a record date of March 6, 2026, to decide who could participate. The ratio was fixed at 9:47, meaning you could buy 9 new shares for every 47 shares you already owned. Looking at their financials, the company saw a good jump in profit after tax (PAT) in 2025, reaching Rs. 1.82 crores. This is a big recovery from the Rs. 0.17 crores reported in 2024. Investors who participated can see these new shares listed on the BSE.
PayPay has officially priced its massive IPO on the NASDAQ Global Select exchange under the symbol PAYP. As a leader in Japan's cashless payment market, the company provides an all-in-one app for banking, shopping, and credit. They offered over 5.49 crore shares at a price of $16.00 each. The total offer amount reached a huge $879.79 million. This is a major deal for those who want to invest in the shift toward digital money in Asia.
The company has a large team of over 4,100 employees and a strong network of millions of users and merchants. For those trading this stock, it is important to note the 180-day lockup period. This lockup expires on September 8, 2026, which is the first time many insiders can sell their shares. With a quiet period ending on April 21, 2026, we can expect more research reports to come out soon.
Freecast is taking a different approach to the entertainment world by offering a service that brings all your favorite shows into one place. Their platform uses a SmartGuide system that works on any Wi-Fi device, like Smart TVs and phones. They recently priced their offering on the NASDAQ Global exchange using the symbol CAST. This was a shareholder-led offering involving 1.97 crore shares. Unlike other deals, this one focused on existing owners selling their stakes.
The company does not just look for individual users; it partners with large brands and device makers to reach more people quickly. Their business model relies on licensing their technology to other firms. Traders should watch the lockup expiration date of September 7, 2026. The quiet period for this stock ends on April 20, 2026. This IPO will show how well a middle-man service can scale in a very crowded streaming market.
Also Read: IPO News: Raajmarg Infra InvIT, Innovision, Kheria Autocomp and 2 More Issues to Watch
MiniMed Group has launched a significant IPO on the NASDAQ Global Select exchange with a share price of $20.00. This company is a global leader in medical technology, focusing specifically on diabetes management for over 40 years. They offered 2.8 crore shares to raise $560 million. With a massive workforce of 8,000 people, MiniMed is the only company that sells every part of an integrated diabetes management system.
The company prides itself on high privacy, security, and better health outcomes for its users. Their tools help people manage their health more easily than older options. The IPO shares are now priced, and the lockup period will end on September 2, 2026. For investors who value long-term stability in the healthcare and medical device sector, this is a large-cap opportunity to watch.
Also Read: SBI Mutual Fund Files IPO Papers with SEBI, Plans to offer 20.37 Crore Shares Via OFS
IPO news today indicates that the market is entering a critical transition phase where regulatory clarity and sectoral shifts will define the next wave of liquidity. The success of large-scale tech offerings like PayPay and MiniMed suggests that institutional appetite for high-growth, platform-based businesses is incredibly strong despite global economic noise.
Investors should keep a close eye on the lockup expiration dates of these major IPOs, as these events often trigger price adjustments and secondary entry points. Furthermore, the steady rise in SME GMPs shows that retail sentiment is still leaning toward risk-on opportunities in specialized industries. Hence, offering a good foundation for a recovery that could extend well into the next quarter.
1. What is the latest IPO news?
IPO activity remains strong even as markets stay volatile due to global tensions and rising oil prices. Apsis Aerocom IPO showed strong grey market demand with a GMP of Rs. 26. Bluegod completed its rights issue, while global IPOs like PayPay and MiniMed raised large amounts. This shows investors are still active in the primary market despite weak secondary market sentiment.
2. What is Apsis Aerocom IPO GMP?
Apsis Aerocom IPO GMP is Rs. 26 as of March 18, which is the highest level seen so far. It started at Rs. 9 earlier and moved up steadily, showing growing demand. Based on the upper price band of Rs. 110, this GMP suggests a possible return of around 23%. This trend indicates strong interest from traders in SME IPOs.
3. What is Bluegod Entertainment rights issue?
Bluegod Entertainment launched a rights issue worth Rs. 31.63 crore at Rs. 3 per share. It allowed existing investors to buy more shares in a 9:47 ratio. The company is trying to expand in media and digital content. Its profit improved in 2025, which makes this issue important for investors tracking turnaround stories in small-cap companies.
4. What are the key details of PayPay and MiniMed IPOs?
PayPay priced its IPO at $16 per share, raising about $879.79 million with over 5.49 crore shares offered. MiniMed priced its IPO at $20, raising $560 million through 2.8 crore shares. Both companies are large global players in fintech and healthcare, and their strong fundraising shows that big investors are still confident in long-term growth sectors.
5. What should investors watch in IPO markets?
Investors should track grey market trends, subscription levels, and lockup expiry dates. GMP gives a quick idea of listing demand, while lockup periods can impact future price movements. Even though markets are volatile, IPOs in sectors like healthcare, fintech, and engineering are attracting steady interest, offering selective opportunities for both traders and long-term investors.
